Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Login and Edit functionality is currently unavailable.

Peter Libby, M.D.

Co-Author

This page shows the publications co-authored by Peter Libby and Eugene Braunwald.
Connection Strength

0.578
  1. Libby P, Willerson JT, Braunwald E. C-reactive protein and coronary heart disease. N Engl J Med. 2004 Jul 15; 351(3):295-8; author reply 295-8.
    View in: PubMed
    Score: 0.322
  2. Libby P, Maroko PR, Braunwald E. The effect of hypoglycemia on myocardial ischemic injury during acute experimental coronary artery occlusion. Circulation. 1975 Apr; 51(4):621-6.
    View in: PubMed
    Score: 0.042
  3. Braunwald E, Maroko PR, Libby P. Reduction of infarct size following coronary occlusion. Circ Res. 1974 Sep; 35 Suppl 3:192-201.
    View in: PubMed
    Score: 0.041
  4. Libby P, Maroko PR, Bloor CM, Sobel BE, Braunwald E. Reduction of experimental myocardial infarct size by corticosteroid administration. J Clin Invest. 1973 Mar; 52(3):599-607.
    View in: PubMed
    Score: 0.037
  5. Libby P, Maroko PR, Covell JW, Malloch CI, Ross J, Braunwald E. Effect of practolol on the extent of myocardial ischaemic injury after experimental coronary occlusion and its effects of ventricular function in the normal and ischaemic heart. Cardiovasc Res. 1973 Mar; 7(2):167-73.
    View in: PubMed
    Score: 0.037
  6. Morrow DA, Wang Y, Croce K, Sakuma M, Sabatine MS, Gao H, Pradhan AD, Healy AM, Buros J, McCabe CH, Libby P, Cannon CP, Braunwald E, Simon DI. Myeloid-related protein 8/14 and the risk of cardiovascular death or myocardial infarction after an acute coronary syndrome in the Pravastatin or Atorvastatin Evaluation and Infection Therapy: Thrombolysis in Myocardial Infarction (PROVE IT-TIMI 22) trial. Am Heart J. 2008 Jan; 155(1):49-55.
    View in: PubMed
    Score: 0.025
  7. Varo N, de Lemos JA, Libby P, Morrow DA, Murphy SA, Nuzzo R, Gibson CM, Cannon CP, Braunwald E, Schönbeck U. Soluble CD40L: risk prediction after acute coronary syndromes. Circulation. 2003 Sep 02; 108(9):1049-52.
    View in: PubMed
    Score: 0.019
  8. Maroko PR, Hillis LD, Muller JE, Tavazzi L, Heyndrickx GR, Ray M, Chiariello M, Distante A, Askenazi J, Salerno J, Carpentier J, Reshetnaya NI, Radvany P, Libby P, Raabe DS, Chazov EI, Bobba P, Braunwald E. Favorable effects of hyaluronidase on electrocardiographic evidence of necrosis in patients with acute myocardial infarction. N Engl J Med. 1977 Apr 21; 296(16):898-903.
    View in: PubMed
    Score: 0.012
  9. Maroko PR, Libby P, Braunwald E. Effect of pharmacologic agents on the function of the ischemic heart. Am J Cardiol. 1973 Dec; 32(7):930-6.
    View in: PubMed
    Score: 0.010
  10. Maroko PR, Libby P, Bloor CM, Sobel BE, Braunwald E. Reduction by hyaluronidase of myocardial necrosis following coronary artery occlusion. Circulation. 1972 Sep; 46(3):430-7.
    View in: PubMed
    Score: 0.009
  11. Maroko PR, Bernstein EF, Libby P, DeLaria GA, Covell JW, Ross J, Braunwald E. Effects of intraaortic balloon counterpulsation on the severity of myocardial ischemic injury following acute coronary occlusion. Counterpulsation and myocardial injury. Circulation. 1972 Jun; 45(6):1150-9.
    View in: PubMed
    Score: 0.009
  12. Maroko PR, Libby P, Sobel BE, Bloor CM, Sybers HD, Shell WE, Covell JW, Braunwald E. Effect of glucose-insulin-potassium infusion on myocardial infarction following experimental coronary artery occlusion. Circulation. 1972 Jun; 45(6):1160-75.
    View in: PubMed
    Score: 0.009
  13. Maroko PR, Libby P, Covell JW, Sobel BE, Ross J, Braunwald E. Precordial S-T segment elevation mapping: an atraumatic method for assessing alterations in the extent of myocardial ischemic injury. The effects of pharmacologic and hemodynamic interventions. Am J Cardiol. 1972 Feb; 29(2):223-30.
    View in: PubMed
    Score: 0.008
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.